|
EXP002068
|
Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based …
|
2024 |
ADGN-PEG
|
CRISPR RNA (Cas9 mRNA + sgRNA)
|
yes |
yes |
|
no |
no |
|
EXP002069
|
Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based …
|
2024 |
ADGN (no YIGSR)
|
CRISPR RNA (Cas9 mRNA + sgRNA)
|
yes |
no |
|
no |
no |
|
EXP002070
|
Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based …
|
2024 |
ADGN (AVA+PEG)
|
CRISPR RNA (Cas9 mRNA + sgRNA)
|
yes |
|
|
yes |
yes |
|
EXP002071
|
Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Pe…
|
2022 |
CRHC-2
|
plasmid DNA / siRNA
|
yes |
yes |
|
no |
no |
|
EXP002072
|
Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Pe…
|
2022 |
M9 (CS-A–mannitol coated)
|
plasmid DNA / siRNA
|
yes |
yes |
|
no |
no |
|
EXP002073
|
Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Pe…
|
2022 |
M9 (CS-A–mannitol coated)
|
plasmid DNA
|
yes |
|
|
yes |
no |
|
EXP002074
|
Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery …
|
2018 |
HIV-Tat
|
plasmid DNA
|
yes |
yes |
yes |
no |
no |
|
EXP002075
|
Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15…
|
2017 |
Tat-LK15
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002076
|
Targeting neuronal nitric oxide synthase by a cell penetrating peptide Tat-LK15…
|
2017 |
Tat-LK15
|
siRNA
|
yes |
no |
|
no |
no |
|
EXP002077
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002078
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M1
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002079
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M2
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002080
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M3
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002081
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M4
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002082
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M5
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002083
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M6
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002084
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M7
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002085
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M8
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002086
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M3
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002087
|
Design and Evaluation of Endosomolytic Biocompatible Peptides as Carriers for s…
|
2015 |
C6M6
|
siRNA
|
no |
|
|
yes |
yes |
|
EXP002088
|
Biomaterial-Mediated Protein Expression Induced by Peptide-mRNA Nanoparticles E…
|
2022 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002089
|
Biomaterial-Mediated Protein Expression Induced by Peptide-mRNA Nanoparticles E…
|
2022 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002090
|
Biomaterial-Mediated Protein Expression Induced by Peptide-mRNA Nanoparticles E…
|
2022 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002091
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
R9
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002092
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
PAS-R9
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002093
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
pHK
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002094
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
R9-pHK
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002095
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
pHK-PAS
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002096
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
PAS-pHK
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002097
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
N-acetylated PAS-pHK
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002098
|
Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mi…
|
2020 |
PAS-pHKscram
|
miRNA
|
yes |
no |
|
no |
no |
|
EXP002099
|
α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide–Cyclic RGD Conjug…
|
2019 |
MAP(Aib)-cRGD
|
miRNA
|
yes |
yes |
|
no |
no |
|
EXP002100
|
Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently pe…
|
2022 |
Lys-thyclotide (anti-miR-21)
|
miRNA
|
no |
|
|
yes |
yes |
|
EXP002101
|
A Novel p19 Fusion Protein as a Delivery Agent for Short-interfering RNAs
|
2016 |
2x-p19-TAT
|
siRNA
|
yes |
yes |
no |
no |
no |
|
EXP002102
|
Engineering a nano-drug delivery system to regulate m6A modification and enhanc…
|
2025 |
YSA + TAT (dual-peptide nanoparticle)
|
small-molecule drug (not RNA)
|
yes |
yes |
|
yes |
yes |
|
EXP002103
|
The osteogenic and angiogenic potential of microRNA-26a delivered via a non-vir…
|
2023 |
RALA
|
DNA plasmid
|
yes |
yes |
|
no |
no |
|
EXP002104
|
The osteogenic and angiogenic potential of microRNA-26a delivered via a non-vir…
|
2023 |
RALA
|
miRNA (plasmid)
|
yes |
yes |
|
no |
no |
|
EXP002105
|
The osteogenic and angiogenic potential of microRNA-26a delivered via a non-vir…
|
2023 |
RALA
|
miRNA mimic
|
no |
|
|
yes |
yes |
|
EXP002106
|
PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in…
|
2023 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002107
|
PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in…
|
2023 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002108
|
PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in…
|
2023 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002109
|
PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in…
|
2023 |
PepFect14 (PF14)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002110
|
PepFect14 mediates the delivery of mRNA into human primary keratinocytes and in…
|
2023 |
PepFect14 (PF14)
|
mRNA
|
no |
|
|
yes |
yes |
|
EXP002111
|
Design of a Biocompatible Hydroxyapatite-Based Nanovehicle for Efficient Delive…
|
2021 |
R8HNPs
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002112
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide A
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002113
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide B
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002114
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide C
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002115
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide D
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002116
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide E
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002117
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide F
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002118
|
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles …
|
2024 |
Peptide C
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002119
|
Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles …
|
2024 |
TAT-iRGD
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002120
|
Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles …
|
2024 |
TAT-iRGD
|
mRNA
|
yes |
|
|
yes |
yes |
|
EXP002121
|
Targeting Listeria monocytogenes consensus sequence of internalin genes using a…
|
2019 |
Arg-rich CPP
|
antisense PNA
|
no |
yes |
|
no |
no |
|
EXP002122
|
Photo inducible RNA interference using cell permeable protein carrier
|
2007 |
Tat-UIA
|
siRNA / shRNA
|
yes |
yes |
yes |
no |
no |
|
EXP002123
|
Use of cell cultures in vitro to assess the uptake of long dsRNA in plant cells
|
2022 |
cCPP (3×Tat-HA-PKR)
|
dsRNA
|
yes |
no |
|
no |
no |
|
EXP002124
|
Effect of small molecule signaling in PepFect14 transfection
|
2020 |
PepFect14 (PF14)
|
splice-correcting oligonucleotide
|
yes |
yes |
yes |
no |
no |
|
EXP002125
|
Supplementation With Cell-Penetrating Peptide-Conjugated Estrogen-Related Recep…
|
2016 |
CPP-ESRRB (7R-ESRRB)
|
mRNA (endogenous regulation)
|
yes |
yes |
|
no |
no |
|
EXP002126
|
Supplementation With Cell-Penetrating Peptide-Conjugated Estrogen-Related Recep…
|
2016 |
CPP-ESRRB (7R-ESRRB)
|
mRNA (endogenous regulation)
|
yes |
|
|
yes |
yes |
|
EXP002127
|
Development of a cell-penetrating peptide-based nanocomplex for long-term deliv…
|
2025 |
RD3AD
|
mtDNA
|
yes |
yes |
yes |
no |
no |
|
EXP002128
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplin–eg1–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002129
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplinN–S–S–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002130
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplinC–S–S–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002131
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplin[2–6]N–S–S–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002132
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplin[2–6]C–S–S–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002133
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K–eg1–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002134
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K–S–S–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002135
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K[2–6]–S–S–PNA
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002136
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K–eg1–PNAmm
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002137
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K–S–S–PNAmm
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002138
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K[2–6]–S–S–PNAmm
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002139
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
(KFF)3K–eg1–PNAcontrol
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002140
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplinN–S–S–PNAmm
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002141
|
Evaluating delivery of peptide nucleic acids to Gram-negative bacteria using me…
|
2024 |
anoplin[2–6]N–S–S–PNAmm
|
PNA
|
yes |
yes |
|
no |
no |
|
EXP002142
|
Cell-penetrating peptide nanocomplexes enhanced cellular uptake of dsRNA in Sf9…
|
2021 |
TAT
|
dsRNA (600 bp)
|
no |
no |
|
no |
no |
|
EXP002143
|
Cell-penetrating peptide nanocomplexes enhanced cellular uptake of dsRNA in Sf9…
|
2021 |
TAT
|
dsRNA (600 bp)
|
yes |
no |
|
no |
no |
|
EXP002144
|
Cell-penetrating peptide nanocomplexes enhanced cellular uptake of dsRNA in Sf9…
|
2021 |
EB1
|
dsRNA (600 bp)
|
no |
no |
|
no |
no |
|
EXP002145
|
Cell-penetrating peptide nanocomplexes enhanced cellular uptake of dsRNA in Sf9…
|
2021 |
EB1
|
dsRNA (600 bp)
|
yes |
no |
yes |
no |
no |
|
EXP002146
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 1)
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002147
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 2)
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP002148
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 3)
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP002149
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 4)
|
mRNA
|
no |
yes |
|
no |
no |
|
EXP002150
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 1)
|
mRNA
|
no |
|
|
yes |
no |
|
EXP002151
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 2)
|
mRNA
|
no |
|
|
yes |
no |
|
EXP002152
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 3)
|
mRNA
|
no |
|
|
yes |
no |
|
EXP002153
|
Synthesis of cell penetrating peptide sterol coupler and its liposome study on …
|
2023 |
chol-CGYKK (Liposome 4)
|
mRNA
|
no |
|
|
yes |
no |
|
EXP002154
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6
|
siRNA
|
no |
|
|
no |
no |
|
EXP002155
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M
|
siRNA
|
no |
|
|
no |
no |
|
EXP002156
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M1
|
siRNA
|
no |
|
|
no |
no |
|
EXP002157
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M2
|
siRNA
|
no |
|
|
no |
no |
|
EXP002158
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M3
|
siRNA
|
no |
|
|
no |
no |
|
EXP002159
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M4
|
siRNA
|
no |
|
|
no |
no |
|
EXP002160
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M5
|
siRNA
|
no |
|
|
no |
no |
|
EXP002161
|
Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes
|
2022 |
C6M6
|
siRNA
|
no |
|
|
no |
no |
|
EXP002162
|
A peptide conjugate enables systemic injection of the morpholino inducer and mo…
|
2025 |
v-M8
|
morpholino oligonucleotide (PMO)
|
no |
|
yes |
yes |
yes |
|
EXP002163
|
A peptide conjugate enables systemic injection of the morpholino inducer and mo…
|
2025 |
B-M8
|
morpholino oligonucleotide (PMO)
|
no |
|
yes |
yes |
yes |
|
EXP002164
|
A peptide conjugate enables systemic injection of the morpholino inducer and mo…
|
2025 |
B-MSP-M8
|
morpholino oligonucleotide (PMO)
|
no |
|
yes |
yes |
yes |
|
EXP002165
|
Low Molecular Weight Alginate Oligosaccharides as Alternatives to PEG for Enhan…
|
2024 |
Peptide E
|
mRNA
|
yes |
yes |
|
no |
no |
|
EXP002166
|
Low Molecular Weight Alginate Oligosaccharides as Alternatives to PEG for Enhan…
|
2024 |
Peptide Y
|
siRNA
|
yes |
yes |
|
no |
no |
|
EXP002167
|
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs
|
2023 |
TAT
|
siRNA (designed in silico)
|
yes |
no |
|
no |
no |